新聞Cdrd launched Executive Institute program on Sep 21st '18.The Centre for Drug Research and Development, with support of Pfizer Canada, announced the launch of the Executive Institute program, a distinct stream of The CDRD Academy, earlier this year.
新聞Cdrd is developing novel immuno-oncology monoclonal antibodies on May 30th '18.Schrödinger, Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods, announced today that it has established a collaboration with Canada’s national Centre for Drug Research and Development (CDRD), to develop novel immuno-oncology monoclonal antibodies and other cancer biologics.
